CHE Chemed Corp

  1. Stocks
  2. Healthcare
  3. NYSE: CHE

Price (delayed)

$533.65

Market cap

$6.95B

P/E Ratio

25.5

Dividend/share

$2.5

EPS

$20.93

Enterprise value

$7.29B

?
Relative Growth: Rel. Growth: 54
Relative Strength: Rel. Strength: 74
Relative Valuation: Rel. Valuation: 49
Relative Profitability: Rel. Profitability: 71

Chemed Corporation (Chemed) purchases, operates and divests subsidiaries engaged in diverse business activities. During the year ended December 31, 2012, Chemed operated in two segments: the Vitas segment (Vitas) and ...

Highlights
The EPS has increased by 10% YoY and by 5% from the previous quarter
CHE's gross profit is up by 7% year-on-year and by 3.9% since the previous quarter
Chemed's quick ratio has increased by 28% from the previous quarter but it has decreased by 22% YoY
Chemed's equity has decreased by 20% YoY but it has increased by 3.7% from the previous quarter
The debt has soared by 177% year-on-year and by 33% since the previous quarter
Sector: Healthcare
Industry: Medical Care Facilities
Website: http://www.chemed.com
Peers: SXT BCPC RPM

Key stats

What are the main financial stats of CHE

CHE stock price

How has the Chemed stock price performed over time
Intraday
-1.57%
1 week
4.82%
1 month
5.15%
1 year
21.1%
YTD
24.73%
QTD
5.66%

Financial performance

How have Chemed's revenue and profit performed over time
Revenue
$2.66B
Gross profit
$895.37M
Operating income
$370.86M
Net income
$282.4M
Gross margin
33.6%
Net margin
10.6%
CHE's gross profit is up by 7% year-on-year and by 3.9% since the previous quarter
Chemed's operating income has increased by 6% from the previous quarter and by 6% YoY
The revenue rose by 5% year-on-year and by 2.5% since the previous quarter
The net margin is down by 3.6% year-on-year

Price vs fundamentals

How does CHE's price correlate with its fundamentals

Growth

What is Chemed's growth rate over time

Valuation

What is Chemed stock price valuation
CHE P/E details
P/E
25.5
P/B
8.1
P/S
2.62
EV/EBIT
18.82
EV/EBITDA
16.03
EV/Sales
2.74
The price to earnings (P/E) is 14% higher than the last 4 quarters average of 22.8 but 8% lower than the 5-year quarterly average of 28.1
The EPS has increased by 10% YoY and by 5% from the previous quarter
Chemed's equity has decreased by 20% YoY but it has increased by 3.7% from the previous quarter
The P/B is 19% more than the last 4 quarters average of 6.9
CHE's P/S is 19% below its 5-year quarterly average of 3.3 but 16% above its last 4 quarters average of 2.3
The revenue rose by 5% year-on-year and by 2.5% since the previous quarter

Efficiency

How efficient is Chemed business performance
The ROE has grown by 32% YoY and by 9% from the previous quarter
The company's return on invested capital fell by 16% YoY and by 7% QoQ
The ROA rose by 7% year-on-year

Dividends

What is CHE's dividend history
Dividend details
DPS
$2.5
Dividend yield
0.47%
Payout ratio
11.9%
Recent dividends

Special dividends are included in TTM DPS and yield

Financial health

How did Chemed financials performed over time
Chemed's total assets is 101% higher than its total liabilities
The total liabilities has soared by 57% YoY and by 14% QoQ
Chemed's quick ratio has increased by 28% from the previous quarter but it has decreased by 22% YoY
The debt is 54% smaller than the equity
The debt has soared by 177% year-on-year and by 33% since the previous quarter
CHE's debt to equity is up by 31% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.